The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000789369
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
2/06/2026
Date registered
Help: Date registered
1/07/2026
Date last updated
Help: Date last updated
25/08/2026
Date data sharing statement initially provided
Help: Data sharing statement date
1/07/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Objective assessment of a digital therapeutic for adults with tinnitus
Scientific title
Objective assessment of a digital therapeutic for adults with tinnitus using functional near infrared spectroscopy (fNIRS): assessing the impact on symptoms and related distress’
Additional trial identifiers [1] 317188 0
Nil
Universal Trial Number (UTN)
Trial acronym
NIRVANA Study (Near InfraRed Visualisation and Analysis of Neuroplastic Adaptation in tinnitus)
Related trial records

Health condition
Health condition(s) studied:
Tinnitus 341769 0
Condition category
Condition code
Ear 337845 337845 0 0
Other ear disorders
Neurological 337846 337846 0 0
Other neurological disorders

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
The aim of this study is to examine whether the effects of using a new treatment for tinnitus management can be objectively measured. The new treatment is a digital therapeutic for tinnitus management called Oto which is accessed via a smartphone app.

To do this, two groups of people with tinnitus – one group consistently using the Oto app for three months (intervention arm) and another not using the app at all (control arm) – will have assessments taken at two timepoints 3-3.5 months apart.

Oto is a digital therapeutic combining cognitive behavioural therapy (CBT) with mindfulness, patient education and app-delivered physical relaxation exercises and gentle stretches designed to help users manage bodily tension that can accompany tinnitus-related stress. These may include simple guided neck, shoulder, jaw or upper-body stretches, breathing-based relaxation, and exercises aimed at releasing muscle tension. These are not delivered as formal physiotherapy and are not individually prescribed by a physiotherapist. They are provided within the Oto app as recorded self-guided audio/digital content. Oto’s programme offers a series of therapy sessions, where the user listens to recorded audio content that takes them through education, cognitive exercise or a tinnitus-specific meditation. Users work their way through progressive modules at their own pace using a spiral curriculum, where the sessions build on techniques and exercises learned in previous sessions. Users can personalise their therapy by listening to additional modules and sounds from the sound library.

Supplementary modules and tools accessible through the app may cover areas such as understanding tinnitus, habituation, changing unhelpful responses to tinnitus, managing tinnitus-related distress, relaxation, sleep, stress, concentration/focus, mindfulness, and coping with tinnitus spikes. The app also includes a sound library with sound therapy options and soundscapes, such as nature sounds or white/ambient noise, which users may use to support relaxation, focus, sleep and habituation.

These resources have not been developed specifically for this study. They are pre-existing Oto app resources developed by Oto Health Ltd and available within the Oto digital therapeutic.

CBT techniques that Oto may teach include:
-Attention redirection - deliberately shifting focus away from the tinnitus and toward other sounds or activities.
-Behavioural experiments -testing beliefs such as “I can’t concentrate when my tinnitus is loud” by trying a task and observing what happens.
-Relaxation and mindfulness exercises - learning to notice tinnitus without reacting emotionally to it.
-Habituation training - teaching the brain to treat tinnitus as an unimportant background sound.

At-home use of the Oto app will be supported via three online meetings with an audiologist to assist onboarding, goal-setting and engagement with the programme.. These online sessions will be interspaced throughout the 3-month use of the app.

The Oto app will record engagement with the app by participants such as frequency of use, overall duration of use and number of modules completed. The audiologist will access these engagement analytics and will discuss them with participants during the online sessions.

Timeline of participation is described below,

1) Baseline visit (1-2 hours) (Day 0): Participants will be asked to complete an initial visit to get a baseline assessment. Assessments include: functional near-infrared spectroscopy (fNIRS) imaging, pure tone audiometry and questionnaires about tinnitus, stress and mental health.

After the baseline visit, participants can self-select if they would like to be involved in the intervention group or the control group.

2) Intervention group only: Initial online meeting (90 mins) (up to 7 days from baseline visit): Participants in the intervention group will be booked into an online meeting with the study audiologist within one week of their baseline visit. During this meeting, participants will be asked to download and install the Oto app. The audiologist will support with setup and onboarding. They will also discuss with participants how often they should use the app. This can vary depending on each participant’s CBT program goals (e.g., complete 20 sessions within the next 4 weeks). Goals discussed will be recorded by the audiologist in a study-specific database. Usage of the app depends on goals discussed with the audiologist but could be as often as once a day at most for the duration of the study. Engagement with the Oto app by participants will be recorded in-app, including frequency of use, overall duration of use and number of modules completed. The audiologist will not deliver tinnitus counselling and will only support with the use of the app.

3) Intervention group only: 2nd online meeting (20-60 mins) (1 month after starting use of the Oto app): Participants will be asked to attend a 2nd online meeting with the study audiologist. During this meeting, the audiologist will review the participant’s use of the app, how the participant is tracking against the goals set during the first online meeting (e.g., how many sessions have they completed compared to the goal agreed upon 4 weeks ago), help problem-solve barriers if goals were unmet, and set new goals for the remaining duration of the study. New goals will again be recorded by the study audiologist. The participant is also free to ask any app-use questions they may have.

4) Intervention group only: 3rd online meeting (20-60 mins) (3 months after starting use of the Oto app): Participants will be asked to attend the 3rd and final online meeting with the study audiologist. During this meeting, the audiologist will review the participant’s use of the app, review adherence and discuss steps for post-trial care. The participant is also free to ask any app-use questions they may have.

5) Follow-up visit (1-2 hours) (3-3.5 months from baseline visit): Participants (both intervention and control groups) will be asked to complete a second visit for a follow-up assessment. The assessments performed during this visit will be the same as the ones performed during the baseline visit. This visit is scheduled up to one week after their 3rd online meeting with the study audiologist.
Intervention code [1] 333956 0
Behaviour
Intervention code [2] 333957 0
Treatment: Other
Description of the comparator or control
Timeline of control group participation is described below,

1) Baseline visit (1-2 hours) (Day 0): Participants will be asked to complete an initial visit to get a baseline assessment. Assessments include: functional near-infrared spectroscopy (fNIRS) imaging, pure tone audiometry and questionnaires about tinnitus, stress and mental health.

2) Follow-up visit (1-2 hours) (3 months from baseline visit): Participants will be asked to complete a second visit for a follow-up assessment. The assessments performed during this visit will be the same as the ones performed during the baseline visit

The control group will not be given access to the app during their participation. They will be offered access to the app once their participation in the study has been completed (3 months after their baseline visit and after completing follow-up visit).
Control group
Active

Outcomes
Primary outcome [1] 345410 0
Cortical activity at rest, and in response to auditory and visual stimuli assessed together as a composite primary outcome.
Timepoint [1] 345410 0
For the control group, at baseline and at 12 weeks post-baseline. For the intervention group, at baseline and at up to 1 week after using the app for 12 weeks.
Primary outcome [2] 345430 0
Subjective ratings of tinnitus
Timepoint [2] 345430 0
For the control group, at baseline and at 12 weeks post-baseline. For the intervention group, at baseline and at up to 1 week after using the app for 12 weeks.
Primary outcome [3] 345758 0
Subjective ratings of tinnitus-related distress
Timepoint [3] 345758 0
For the control group, at baseline and at 12 weeks post-baseline. For the intervention group, at baseline and at up to 1 week after using the app for 12 weeks.
Secondary outcome [1] 461620 0
Primary outcome [4]: Subjective ratings of tinnitus-related handicap
Timepoint [1] 461620 0
For the control group, at baseline and at 12 weeks post-baseline. For the intervention group, at baseline and at up to 1 week after using the app for 12 weeks.
Secondary outcome [2] 461621 0
Current emotional state
Timepoint [2] 461621 0
For the control group, at baseline and at 12 weeks post-baseline. For the intervention group, at baseline and at up to 1 week after using the app for 12 weeks.
Secondary outcome [3] 461622 0
Perceived stress
Timepoint [3] 461622 0
For the control group, at baseline and at 12 weeks post-baseline. For the intervention group, at baseline and at up to 1 week after using the app for 12 weeks.
Secondary outcome [4] 463189 0
Current hearing levels
Timepoint [4] 463189 0
For the control group, at baseline and at 12 weeks post-baseline. For the intervention group, at baseline and at up to 1 week after using the app for 12 weeks.

Eligibility
Key inclusion criteria
-Adults aged 18 and over
-Experience constant tinnitus
-Own a compatible smartphone and willing to use Oto (smartphone app)
-If on neurological or psychiatric medication or receiving psychological or psychiatric support, able to remain on the same type and dose of medication, and/or support arrangements, for four weeks prior to, and the duration of, trial participation
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
-Has pulsatile tinnitus
-Has slight tinnitus
-Undergoing any form of treatment for tinnitus

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC

Funding & Sponsors
Funding source category [1] 321771 0
Charities/Societies/Foundations
Name [1] 321771 0
Bionics Institute
Country [1] 321771 0
Australia
Funding source category [2] 322028 0
Commercial sector/Industry
Name [2] 322028 0
Oto Health Ltd
Country [2] 322028 0
United Kingdom
Primary sponsor type
Charities/Societies/Foundations
Name
Bionics Institute
Address
Country
Australia
Secondary sponsor category [1] 324907 0
None
Name [1] 324907 0
Address [1] 324907 0
Country [1] 324907 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320314 0
St Vincent's Hospital Melbourne Human Research Ethics Committee
Ethics committee address [1] 320314 0
Ethics committee country [1] 320314 0
Australia
Date submitted for ethics approval [1] 320314 0
12/02/2026
Approval date [1] 320314 0
24/04/2026
Ethics approval number [1] 320314 0
044/26

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 150058 0
A/Prof Mehrnaz Shoushtarian
Address 150058 0
The Bionics Institute of Australia, Daly Wing, St Vincent's Hospital Level 7, 35 Victoria Parade FITZROY VIC 3065
Country 150058 0
Australia
Phone 150058 0
+61 3 9377 9934
Fax 150058 0
Email 150058 0
Contact person for public queries
Name 150059 0
Michelle Bravo
Address 150059 0
The Bionics Institute of Australia, Daly Wing, St Vincent's Hospital Level 7, 35 Victoria Parade FITZROY VIC 3065
Country 150059 0
Australia
Phone 150059 0
+61 3 9377 9935
Fax 150059 0
Email 150059 0
Contact person for scientific queries
Name 150060 0
Mehrnaz Shoushtarian
Address 150060 0
The Bionics Institute of Australia, Daly Wing, St Vincent's Hospital Level 7, 35 Victoria Parade FITZROY VIC 3065
Country 150060 0
Australia
Phone 150060 0
+61 3 9377 9934
Fax 150060 0
Email 150060 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.